Literature DB >> 3032049

Hormone-like activity of human thrombin.

R Bar-Shavit, K A Hruska, A J Kahn, G D Wilner.   

Abstract

Recently, we have shown that thrombin is a chemotaxin and growth-promoting agent for cells of the mononuclear phagocytic lineage. These activities are independent of thrombin's enzymatic activity. Unlike other chemotactic factors, thrombin is specific for monocytes and does not attract granulocytes. To further explore the cellular specificity we have used a human leukemia cell line HL-60 that is capable of in vitro differentiation toward either monocytes (HL-60/mono) following incubation with 1,25(OH)2D3, or granulocytes (HL-60/gran) following incubation with DMSO. In contrast to undifferentiated HL-60 cells or HL-60/gran, we find that HL-60/mono respond chemotactically to intact human alpha-thrombin, esterolytically inactive iPR2P-alpha-thrombin, and the thrombin-derived peptide CB67-129, previously shown to contain the thrombin chemotactic exosite. In addition, thrombin induces in HL-60/mono association of actin with the cytoskeleton and causes an increase in levels of free cytosolic Ca2+. These phenomena are well characterized as early events occurring concomitant with directed cell movement associated with exposure to chemotactic agents such as FMLP. Furthermore, in contrast to fibroblasts, both iPR2P-alpha-thrombin and the thrombin chemotactic peptide CB67-129 evoke dose-dependent [3H]TdR incorporation, protein synthesis, and cell replication in growth-arrested J-744 cells, a murine macrophage-like cell line. Limited tryptic digests of CB67-129 lose chemotactic activity but retain full mitogenic activity, demonstrating that as with PDGF, the sites on CB67-129 required for chemotaxis and mitogenesis are clearly dissociable. The mitogenic effects of the CB67-129 digest can be mimicked by a synthetic tetradecapeptide analogue of CB67-129 (residues 367-380) that includes the loop B insertion sequence, previously shown to be critical for thrombin's chemotactic effects. From these data, it is apparent that the loop B insertion is critical for thrombin's nonenzymic biological effects on cells, but additional sites are required for stimulation of cell movement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3032049     DOI: 10.1111/j.1749-6632.1986.tb34595.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

2.  Quantitative detection of thrombin activity in an ischemic stroke model.

Authors:  Doron Bushi; Joab Chapman; Aviva Katzav; Efrat Shavit-Stein; Noa Molshatzki; Nicola Maggio; David Tanne
Journal:  J Mol Neurosci       Date:  2013-07-31       Impact factor: 3.444

3.  Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.

Authors:  R C Chambers; K Dabbagh; R J McAnulty; A J Gray; O P Blanc-Brude; G J Laurent
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

4.  Single-pair fluorescence resonance energy transfer (spFRET) for the high sensitivity analysis of low-abundance proteins using aptamers as molecular recognition elements.

Authors:  Wonbae Lee; Anne Obubuafo; Yong-Ill Lee; Lloyd M Davis; Steven A Soper
Journal:  J Fluoresc       Date:  2009-10-03       Impact factor: 2.217

5.  Contractile effects of thrombin in porcine pulmonary arteries and the influence of thrombin inhibitors.

Authors:  E Glusa; E Bretschneider; M Paintz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

6.  A Linear Temporal Increase in Thrombin Activity and Loss of Its Receptor in Mouse Brain following Ischemic Stroke.

Authors:  Doron Bushi; Efrat Shavit Stein; Valery Golderman; Ekaterina Feingold; Orna Gera; Joab Chapman; David Tanne
Journal:  Front Neurol       Date:  2017-04-10       Impact factor: 4.003

7.  A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.

Authors:  A P Wilson; H Fox; I V Scott; H Lee; M Dent; P R Golding
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.